Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy

Medicine & Life Sciences

• Cholesterol 17%
• Chronic Disease 4%
• Clinical Studies 4%
• Coronary Artery Disease 4%
• Diabetes Complications 5%
• Diabetic Angiopathies 86%
• Enzymes 3%
• glutaryl-coenzyme A 100%
• GTP-Binding Proteins 5%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 63%
• Inflammation 3%
• Lipids 7%
• Morbidity 3%
• Mortality 2%
• Oxidative Stress 4%
• Oxidoreductases 59%
• Post Translational Protein Processing 6%
• Proteins 2%
• Research Personnel 4%
• Serum 2%
• Terpenes 14%
• Therapeutics 0%

Chemistry

• Cholesterol 10%
• Coagulation 6%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 93%
• Isoprenoid 15%
• Lipid 4%
• Modification 3%
• Oxidative Stress 5%
• Protein 4%
• Reduction 2%